Richard Chin
CEO of Ambrosia BioLongevity | Managing Director of Ascendant Venture | Blogs at richardychin.medium.com and clinicaltrialist.com
San Francisco, California
Invests in
Sectors:
Locations:
Min Investment:
$50,000.00Max Investment:
$1,000,000.00Target Investment:
$100,000.00
Education
Lists including Richard
Work Experience
2024
Founder and Chief Executive Officer
2024
Biopharmaceutical company developing therapies to cure aging
2022
Managing Director
2022
Early stage investment fund, with a focus on justice tech and other impact-oriented investments
2023
Co-Founder and Chairman of the Board of Directors
2023
Biotech company bringing affordable biologics to patients in Africa and other LMICs
2022
Co-Founder and Chairman of the Board of Directors
2022
Developing life-changing monoclonal antibodies for pets
Board Member
2021
Nonprofit organization supporting Asian American films
2021 - 2023
Board Member
2021 - 2023
Nonprofit organization dedicated to preserving endangered languages across the planet
2012 - 2021
Founder and Chief Executive Officer
2012 - 2021
Founder and CEO of KindredBio (NASDAQ:KIN), a biotech company developing drugs and biologics for pets (acquired by Elanco)
2010 - 2020
Clinical Associate Professor
2010 - 2020
2011 - 2018
Board Member
2011 - 2018
Biotech company developing therapies for neurological diseases.
2013 - 2014
Board Member
2013 - 2014
CRISPR company founded by Jennifer Doudna, who won the Nobel Prize for CRISPR